AcceXible Speech-Based Screening for Depression and Anxiety in University Students (UAQ, Mexico)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16-25
SponsorAccexible

About this trial

Major depressive disorder (MDD) and anxiety are increasingly prevalent among university student populations, yet early detection remains reliant on psychometric instruments tied to diagnostic criteria (e.g., PHQ-9, GAD). Emerging evidence suggests that depression affects both the acoustic properties and content of speech, making speech analysis a promising candidate as a digital biomarker for early screening.

This study evaluates the validity of acceXible, a speech-based machine learning platform, for the detection and monitoring of depression and anxiety in the student population of the Universidad Autónoma de Querétaro, Mexico. AcceXible captures spontaneous speech through open-ended interview tasks and applies automated acoustic and linguistic analysis.

The primary objective is to evaluate the validity of the acceXible spontaneous speech analysis system for depression and anxiety screening, assessed against the PHQ and GAD scales as reference standards. Secondary objectives include examining associations between speech-derived variables and other study measures, evaluating participant engagement with digital mental health resources, assessing user satisfaction with the platform, and analyzing longitudinal changes in scores across follow-up assessments.

Eligibility criteria

Qualifiers

Provision of voluntary written informed consent

Age 16-25 years

Current enrollment at BUAP

Spanish language proficiency

Disqualifiers

Refusal to participate

Psychomotor agitation

Sensory impairment (visual or auditory)

Cognitive impairment

Trial design

Treatments tested in this trial

  • Accexible

Treatment groups

No treatment groups listed

Sponsors and collaborators

Accexible

Lead sponsor

Universidad Autónoma de Querétaro

Collaborator